Professor Riccardo Rosati is the Head of the Gastrointestinal Surgery (GI) Department at the San Raffaele Research Hospital in Milan, Italy. He is a highly experienced surgeon with over 30 years of experience, having completed medical degrees in general medicine and general surgery, as well as specialization in thoracic surgery. He is a member of multiple surgical associations, and has written over 300 publications. His department treats approximately 2,000 surgical cases per year.
Read moreProfessor Riccardo Rosati is the Head of the Gastrointestinal Surgery (GI) Department at the San Raffaele Research Hospital in Milan, Italy. He is a highly experienced surgeon with over 30 years of experience, having completed medical degrees in general medicine and general surgery, as well as specialization in thoracic surgery. He is a member of multiple surgical associations, and has written over 300 publications. His department treats approximately 2,000 surgical cases per year.
Dr. is the Director of the Endocrine and Bariatric Surgery Unit and Head of the Mater Olbia Hospital Bariatric Center. He has a Degree in Medicine and Surgery from the School of Medicine at the Università Cattolica del Sacro Cuore in Rome, Italy, and a Certificate of Specialist in General Surgery from the same school. His main focus is laparoscopic surgical approaches to morbid obesity and endocrine diseases, with a special interest in minimally invasive techniques. He has performed over 4500 surgical procedures, including 1500 as the first operator, and has taught at the School of Medicine and the National School of Endocrine Surgery of the Italian Society of Surgery.
Read moreDr. is the Director of the Endocrine and Bariatric Surgery Unit and Head of the Mater Olbia Hospital Bariatric Center. He has a Degree in Medicine and Surgery from the School of Medicine at the Università Cattolica del Sacro Cuore in Rome, Italy, and a Certificate of Specialist in General Surgery from the same school. His main focus is laparoscopic surgical approaches to morbid obesity and endocrine diseases, with a special interest in minimally invasive techniques. He has performed over 4500 surgical procedures, including 1500 as the first operator, and has taught at the School of Medicine and the National School of Endocrine Surgery of the Italian Society of Surgery.
He graduated in Medicine and Surgery from the University of Padua, where, in 1996, he obtained the specialization in Endocrinology, Diabetology and Metabolic Diseases. In 1994 he specialized in Metabolic Diseases from the San Bortolo University Hospital in Vicenza. Engaged in research activities in the areas of use of engineered tissues and growth factors for tissue regeneration, new technologies in the field of conservative surgical treatment, and extreme percutaneous revascularization protocols. He has been chairman of several international courses on Diabetic Foot and Charcot Foot and he is a member of the Editorial Board of the journal "Diabetic Foot and Ankle", and of the European Diabetic Foot Study Group (DFSG).
Author of over 100 scientific publications and about 300 speeches at international congresses, including several editions of the National Congress of the Diabetes Doctors Association or the Italian Journal of Diabetology.
Awarded with "Ilizarov Award of Excellence" at the International External Fixation Symposium, 2018; -“Paul Brand Memorial Lecture” Award in 2016.
Read moreHe graduated in Medicine and Surgery from the University of Padua, where, in 1996, he obtained the specialization in Endocrinology, Diabetology and Metabolic Diseases. In 1994 he specialized in Metabolic Diseases from the San Bortolo University Hospital in Vicenza. Engaged in research activities in the areas of use of engineered tissues and growth factors for tissue regeneration, new technologies in the field of conservative surgical treatment, and extreme percutaneous revascularization protocols. He has been chairman of several international courses on Diabetic Foot and Charcot Foot and he is a member of the Editorial Board of the journal "Diabetic Foot and Ankle", and of the European Diabetic Foot Study Group (DFSG).
Author of over 100 scientific publications and about 300 speeches at international congresses, including several editions of the National Congress of the Diabetes Doctors Association or the Italian Journal of Diabetology.
Awarded with "Ilizarov Award of Excellence" at the International External Fixation Symposium, 2018; -“Paul Brand Memorial Lecture” Award in 2016.
Prof. Andrea Lania has graduated at the Università degli Studi of Milan and is specialized in endocrinology. He is the Unit Director of Endocrinology and Diabetology in Humanitas Research Hospital and his specialization is pituitary diseases, pituitary adenomas, thyroid cancer, pancreatic neuroendocrine tumors, poorly differentiated neuroendocrine carcinomas.
Medical areas of interest:
Pituitary tumors, hypopituitarism, acromegaly, Cushing’s disease and syndrome, neuroendocrine tumors, thyroid and thyroid diseases, adrenal and adrenal diseases, hypogonadism.
Research areas of interest:
Study of the pathogenetic mechanisms of pituitary and neuroendocrine tumors, of the molecular mechanisms responsible for the different response of pituitary and neuroendocrine tumors to medical therapy.
Prof. Lania published 198 peer-reviewed papers (Google Scholar H-Index 47; Scopus H-Index 38, cit tot 4604)
Prof. Lania has a long standing expertise in the field of intra-cellular signaling in endocrine tumors. In particular, in the past ten years, he contributed to analyze the role of PKA regulatory subunits in the pathogenesis and control of cell proliferation of endocrine tumors. Moreover, he contributed to define the role of SSTR5 domains involved in the intracellular trafficking of this receptor in human pituitary cells and to analyze the impact of DR2R and SSTR2&5 polymorphic variants on both the clinical outcome and response to medical treatment in patients with pituitary tumors.
Recently, he contributed to identify the role of cytoskeleton protein FLNA in mediating both intracellular signaling and membrane targeting of somatostatin type 2 receptor and D2R in pituitary and pancreatic neuroendocrine tumors. Finally, he contributed to explore the intracellular mechanisms possibly involved in mediating the interplay between drugs commonly used in the treatment of neuroendocrine tumors.
Previous experience:
2005-2008 Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy
Director of Endocrinologic Day Hospital and surgery on pituitary disorders.
Publications: https://www.ncbi.nlm.nih.gov/pubmed?term=lania%20A
Read moreProf. Andrea Lania has graduated at the Università degli Studi of Milan and is specialized in endocrinology. He is the Unit Director of Endocrinology and Diabetology in Humanitas Research Hospital and his specialization is pituitary diseases, pituitary adenomas, thyroid cancer, pancreatic neuroendocrine tumors, poorly differentiated neuroendocrine carcinomas.
Medical areas of interest:
Pituitary tumors, hypopituitarism, acromegaly, Cushing’s disease and syndrome, neuroendocrine tumors, thyroid and thyroid diseases, adrenal and adrenal diseases, hypogonadism.
Research areas of interest:
Study of the pathogenetic mechanisms of pituitary and neuroendocrine tumors, of the molecular mechanisms responsible for the different response of pituitary and neuroendocrine tumors to medical therapy.
Prof. Lania published 198 peer-reviewed papers (Google Scholar H-Index 47; Scopus H-Index 38, cit tot 4604)
Prof. Lania has a long standing expertise in the field of intra-cellular signaling in endocrine tumors. In particular, in the past ten years, he contributed to analyze the role of PKA regulatory subunits in the pathogenesis and control of cell proliferation of endocrine tumors. Moreover, he contributed to define the role of SSTR5 domains involved in the intracellular trafficking of this receptor in human pituitary cells and to analyze the impact of DR2R and SSTR2&5 polymorphic variants on both the clinical outcome and response to medical treatment in patients with pituitary tumors.
Recently, he contributed to identify the role of cytoskeleton protein FLNA in mediating both intracellular signaling and membrane targeting of somatostatin type 2 receptor and D2R in pituitary and pancreatic neuroendocrine tumors. Finally, he contributed to explore the intracellular mechanisms possibly involved in mediating the interplay between drugs commonly used in the treatment of neuroendocrine tumors.
Previous experience:
2005-2008 Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy
Director of Endocrinologic Day Hospital and surgery on pituitary disorders.
Publications: https://www.ncbi.nlm.nih.gov/pubmed?term=lania%20A
20 top ranked Endocrinology doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.
The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.
Top 5 Endocrinology doctors on Bookimed.com:
The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.
Famous Endocrinology doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.
The price for the consultation on Endocrinology varies between experts and depends on certain factors, such as:
To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.
We can help to find the right doctors for Endocrinology if you have any difficulties with a choice. Bookimed services are free for patients ♥
Prof Spiezia works for our private clinic in Naples, Clinica Ruesch. He is also the Head of the Endocrine Surgery Operative Unit at Ospedale del Mare Hospital, specializing in surgical procedures related to endocrine disorders, particularly thyroid and adrenal surgeries. He is also the Head of the Endocrine Surgery Regional Network, and consultant in the field of diagnostics and ultrasound-interventional therapy.
Professor specializes in all endocrine pathologies with minimally invasive thyroid-saving interventions, on the parathyroids and lymph nodes, through video-assisted techniques, thermoablation with radio frequency for thyroid nodules, microwave thermoablation, and with laser.
He diagnoses the thyroid and lymph nodes by means of ultrasound-guided needle aspiration. Qualified as a robotic surgeon, coordinates training schools in endocrine ultrasound and has promoted various scientific meetings and training courses, emphasizing the care pathways for patients with thyroid pathologies.
EDUCATION
Prof Stefano Spiezia holds a degree in Medicine and Surgery from the University of Naples, graduating cum laude in 1981. He specialized in Emergency Surgery at the same university, obtaining his diploma in 1986. In 1993, he completed a six-month specialization course in Minimally Invasive Surgery, followed by a managerial course in 1996 focused on healthcare organization management. He received accreditation for ultrasound units in 1997 and achieved a II level University Master’s Degree in Endocrine Surgery from the Seconda Università degli studi di Naples in 2007. This extensive educational background underscores his expertise in surgical practice and healthcare management.
PROFESSIONAL ACTIVITY
Stefano Spiezia has held several significant roles both in Italy and internationally, including:
RESEARCH, PUBLICATIONS, MEMBERSHIP
Prof. Stefano Spiezia's research primarily focuses on endocrine disorders, particularly in the context of thyroid and adrenal surgeries: the development and application of minimally invasive surgical techniques, particularly for thyroid and adrenal surgeries, and is recognized as an expert in thermal ablation of the thyroid.
In Clinical Trials, he is the Principal Investigator (PI) of the first in-human clinical trial (NP-TF-024) aimed at treating benign thyroid nodules, which highlights his commitment to advancing treatment options in endocrine surgery.
Stefano Spiezia is a member of several professional societies, including:
His Editorial Roles: Review Editor on the Editorial Board of Thyroid Endocrinology and a member of the Video Endocrinology editorial board in the ATA.
Author of 7 books and 68 scientific publications.
His work has been cited 3,466 times across 2,256 documents, indicating a significant impact in his field.
Read moreProf Spiezia works for our private clinic in Naples, Clinica Ruesch. He is also the Head of the Endocrine Surgery Operative Unit at Ospedale del Mare Hospital, specializing in surgical procedures related to endocrine disorders, particularly thyroid and adrenal surgeries. He is also the Head of the Endocrine Surgery Regional Network, and consultant in the field of diagnostics and ultrasound-interventional therapy.
Professor specializes in all endocrine pathologies with minimally invasive thyroid-saving interventions, on the parathyroids and lymph nodes, through video-assisted techniques, thermoablation with radio frequency for thyroid nodules, microwave thermoablation, and with laser.
He diagnoses the thyroid and lymph nodes by means of ultrasound-guided needle aspiration. Qualified as a robotic surgeon, coordinates training schools in endocrine ultrasound and has promoted various scientific meetings and training courses, emphasizing the care pathways for patients with thyroid pathologies.
EDUCATION
Prof Stefano Spiezia holds a degree in Medicine and Surgery from the University of Naples, graduating cum laude in 1981. He specialized in Emergency Surgery at the same university, obtaining his diploma in 1986. In 1993, he completed a six-month specialization course in Minimally Invasive Surgery, followed by a managerial course in 1996 focused on healthcare organization management. He received accreditation for ultrasound units in 1997 and achieved a II level University Master’s Degree in Endocrine Surgery from the Seconda Università degli studi di Naples in 2007. This extensive educational background underscores his expertise in surgical practice and healthcare management.
PROFESSIONAL ACTIVITY
Stefano Spiezia has held several significant roles both in Italy and internationally, including:
RESEARCH, PUBLICATIONS, MEMBERSHIP
Prof. Stefano Spiezia's research primarily focuses on endocrine disorders, particularly in the context of thyroid and adrenal surgeries: the development and application of minimally invasive surgical techniques, particularly for thyroid and adrenal surgeries, and is recognized as an expert in thermal ablation of the thyroid.
In Clinical Trials, he is the Principal Investigator (PI) of the first in-human clinical trial (NP-TF-024) aimed at treating benign thyroid nodules, which highlights his commitment to advancing treatment options in endocrine surgery.
Stefano Spiezia is a member of several professional societies, including:
His Editorial Roles: Review Editor on the Editorial Board of Thyroid Endocrinology and a member of the Video Endocrinology editorial board in the ATA.
Author of 7 books and 68 scientific publications.
His work has been cited 3,466 times across 2,256 documents, indicating a significant impact in his field.